pubmed-article:1735443 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:1735443 | lifeskim:mentions | umls-concept:C0003320 | lld:lifeskim |
pubmed-article:1735443 | lifeskim:mentions | umls-concept:C0017978 | lld:lifeskim |
pubmed-article:1735443 | lifeskim:mentions | umls-concept:C0204727 | lld:lifeskim |
pubmed-article:1735443 | lifeskim:mentions | umls-concept:C0205409 | lld:lifeskim |
pubmed-article:1735443 | lifeskim:mentions | umls-concept:C1524075 | lld:lifeskim |
pubmed-article:1735443 | lifeskim:mentions | umls-concept:C1880022 | lld:lifeskim |
pubmed-article:1735443 | lifeskim:mentions | umls-concept:C0231449 | lld:lifeskim |
pubmed-article:1735443 | lifeskim:mentions | umls-concept:C0527042 | lld:lifeskim |
pubmed-article:1735443 | lifeskim:mentions | umls-concept:C0337112 | lld:lifeskim |
pubmed-article:1735443 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:1735443 | pubmed:dateCreated | 1992-3-11 | lld:pubmed |
pubmed-article:1735443 | pubmed:abstractText | A Lewis-b-active glycosphingolipid containing a repetitive type-1 chain carbohydrate core was isolated from human colonic adenocarcinoma cell line Colo205. This glycosphingolipid was purified by HPLC and preparative high-performance thin-layer chromatography and its structure elucidated by positive-ion fast-atom-bombardment mass spectrometry with collision-induced disassociation, 1H-NMR spectroscopy and methylation analysis. The glycosphingolipid was found to be a trifucosylated derivative of this novel carbohydrate core, having the following structure: [formula; see text]. | lld:pubmed |
pubmed-article:1735443 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1735443 | pubmed:language | eng | lld:pubmed |
pubmed-article:1735443 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1735443 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:1735443 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1735443 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1735443 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:1735443 | pubmed:month | Feb | lld:pubmed |
pubmed-article:1735443 | pubmed:issn | 0014-2956 | lld:pubmed |
pubmed-article:1735443 | pubmed:author | pubmed-author:HakomoriSS | lld:pubmed |
pubmed-article:1735443 | pubmed:author | pubmed-author:RobertsC ECE | lld:pubmed |
pubmed-article:1735443 | pubmed:author | pubmed-author:StroudM RMR | lld:pubmed |
pubmed-article:1735443 | pubmed:author | pubmed-author:LeveryS BSB | lld:pubmed |
pubmed-article:1735443 | pubmed:author | pubmed-author:SalyanM EME | lld:pubmed |
pubmed-article:1735443 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:1735443 | pubmed:day | 1 | lld:pubmed |
pubmed-article:1735443 | pubmed:volume | 203 | lld:pubmed |
pubmed-article:1735443 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:1735443 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:1735443 | pubmed:pagination | 577-86 | lld:pubmed |
pubmed-article:1735443 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:1735443 | pubmed:meshHeading | pubmed-meshheading:1735443-... | lld:pubmed |
pubmed-article:1735443 | pubmed:meshHeading | pubmed-meshheading:1735443-... | lld:pubmed |
pubmed-article:1735443 | pubmed:meshHeading | pubmed-meshheading:1735443-... | lld:pubmed |
pubmed-article:1735443 | pubmed:meshHeading | pubmed-meshheading:1735443-... | lld:pubmed |
pubmed-article:1735443 | pubmed:meshHeading | pubmed-meshheading:1735443-... | lld:pubmed |
pubmed-article:1735443 | pubmed:meshHeading | pubmed-meshheading:1735443-... | lld:pubmed |
pubmed-article:1735443 | pubmed:meshHeading | pubmed-meshheading:1735443-... | lld:pubmed |
pubmed-article:1735443 | pubmed:meshHeading | pubmed-meshheading:1735443-... | lld:pubmed |
pubmed-article:1735443 | pubmed:meshHeading | pubmed-meshheading:1735443-... | lld:pubmed |
pubmed-article:1735443 | pubmed:meshHeading | pubmed-meshheading:1735443-... | lld:pubmed |
pubmed-article:1735443 | pubmed:meshHeading | pubmed-meshheading:1735443-... | lld:pubmed |
pubmed-article:1735443 | pubmed:meshHeading | pubmed-meshheading:1735443-... | lld:pubmed |
pubmed-article:1735443 | pubmed:meshHeading | pubmed-meshheading:1735443-... | lld:pubmed |
pubmed-article:1735443 | pubmed:year | 1992 | lld:pubmed |
pubmed-article:1735443 | pubmed:articleTitle | Extended type-1 chain glycosphingolipid antigens. Isolation and characterization of trifucosyl-Leb antigen (III4V4VI2Fuc3Lc6). | lld:pubmed |
pubmed-article:1735443 | pubmed:affiliation | Biomembrane Institute, Seattle, WA 98119. | lld:pubmed |
pubmed-article:1735443 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:1735443 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:1735443 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |